Cargando…
Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant
ERBB2 is an oncogenic receptor tyrosine kinase overexpressed in a subset of human breast cancer and other cancers. We recently found that human prolidase (PEPD), a dipeptidase, is a high affinity ERBB2 ligand and cross-links two ERBB2 monomers. Here, we show that recombinant human PEPD (rhPEPD) stro...
Autores principales: | Yang, Lu, Li, Yun, Bhattacharya, Arup, Zhang, Yuesheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465122/ https://www.ncbi.nlm.nih.gov/pubmed/26086037 http://dx.doi.org/10.1016/j.ebiom.2015.03.016 |
Ejemplares similares
-
Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D
por: Yang, Lu, et al.
Publicado: (2016) -
Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants
por: Yang, Lu, et al.
Publicado: (2021) -
Identification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growth
por: Yang, L, et al.
Publicado: (2014) -
Anticoagulants inhibit proteolytic clearance of plasma amyloid beta
por: Yang, Lu, et al.
Publicado: (2017) -
PEPD is a pivotal regulator of p53 tumor suppressor
por: Yang, Lu, et al.
Publicado: (2017)